Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP753711.RAe9VymfEC0MTsoWCb3toZGSqxvvxcM5p3m6LiAB-urI8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP753711.RAe9VymfEC0MTsoWCb3toZGSqxvvxcM5p3m6LiAB-urI8130_assertion type Assertion NP753711.RAe9VymfEC0MTsoWCb3toZGSqxvvxcM5p3m6LiAB-urI8130_head.
- NP753711.RAe9VymfEC0MTsoWCb3toZGSqxvvxcM5p3m6LiAB-urI8130_assertion wasGeneratedBy ECO_0000203 NP753711.RAe9VymfEC0MTsoWCb3toZGSqxvvxcM5p3m6LiAB-urI8130_provenance.
- NP753711.RAe9VymfEC0MTsoWCb3toZGSqxvvxcM5p3m6LiAB-urI8130_assertion wasDerivedFrom befree-20150227 NP753711.RAe9VymfEC0MTsoWCb3toZGSqxvvxcM5p3m6LiAB-urI8130_provenance.
- NP753711.RAe9VymfEC0MTsoWCb3toZGSqxvvxcM5p3m6LiAB-urI8130_assertion SIO_000772 12376482 NP753711.RAe9VymfEC0MTsoWCb3toZGSqxvvxcM5p3m6LiAB-urI8130_provenance.
- NP753711.RAe9VymfEC0MTsoWCb3toZGSqxvvxcM5p3m6LiAB-urI8130_assertion evidence source_evidence_literature NP753711.RAe9VymfEC0MTsoWCb3toZGSqxvvxcM5p3m6LiAB-urI8130_provenance.
- NP753711.RAe9VymfEC0MTsoWCb3toZGSqxvvxcM5p3m6LiAB-urI8130_assertion description "[Thirty to sixty percent of human bladder cancer has a mutation in the p53 gene, and the mutational spectrum bears two characteristics: compared with other cancers, the pattern of mutations is more evenly distributed along the p53 gene, and the mutational hotspots occur at both CpG sites, such as codons 175, 248 and 273, and non-CpG sites, such as codons 280 and 285, the latter two being unique mutational hotspots for bladder and other urinary tract cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753711.RAe9VymfEC0MTsoWCb3toZGSqxvvxcM5p3m6LiAB-urI8130_provenance.